Quotient Investors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.13M Buy
7,775
+3,934
+102% +$536K 0.78% 52
2017
Q2
$499K Buy
3,841
+355
+10% +$43.5K 0.36% 95
2017
Q1
$434K Buy
+3,486
New +$417K 0.26% 119
2015
Q4
Sell
-3,089
Closed -$334K 267
2015
Q3
$334K Sell
3,089
-3,211
-51% -$398K 0.07% 148
2015
Q2
$729K Buy
+6,300
New +$720K 0.1% 144

Other funds holding CELG

Quotient Investors's CELG Position: Q3 2017 in Review

Quotient Investors increased its Celgene Corp (CELG) stake by 102% in Q3 2017, buying an estimated $536K and bringing the position to 7,775 shares worth $1.13M. The position accounts for 0.78% of the portfolio, ranked #52.

Quotient Investors first reported a position in CELG in Q2 2015 and has held it in 5 quarters since. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • Quotient Investors held 7,775 shares of Celgene Corp worth $1.13M as of Q3 2017.
  • Quotient Investors bought 3,934 Celgene Corp shares in Q3 2017, an estimated $536K.
  • Celgene Corp made up 0.78% of Quotient Investors's portfolio in Q3 2017, its #52 holding.
  • Quotient Investors first reported a position in Celgene Corp in Q2 2015 and has held it in 5 quarters since.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.